FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to chemical-pharmaceutical industry, and concerns an oral preparation containing pregelatinized starch, N-[4-[4-(1,2-benzisothiazol-3-yl)-1-piperazinyl]-(2R,3R)-2,3-tetramethylene-butyl]-(1'R,2'S,3'R,4'S)-2,3-bicyclo[2,2,1] heptanedicarboxyimide hydrochloride (lurasidone) described by formula 
a water-soluble excipient, a water-soluble polymer binding compound; in the declared preparation, lurasidone concentration per a tablet is within 10 to 160 mg, or within 20 to 45 wt/wt % of the preparation weight, and pregelatinised starch is added in amount 10 to 50 wt/wt % of the preparation weight.
EFFECT: preparation shows invariable release behaviour even if changing the concentration of an active ingredient.
17 cl, 3 ex, 39 tbl, 3 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| PHARMACEUTICAL COMPOSITION | 2008 |
|
RU2470637C2 |
| PHARMACEUTICAL COMPOSITIONS WHICH CONTAIN LOBEGLITAZONE FOR ORAL ADMINISTRATION | 2015 |
|
RU2709526C2 |
| PHARMACEUTICAL COMPOSITION OF SLOW RELEASE, CONTAINING APLINDOR AND ITS DERIVATIVES | 2004 |
|
RU2376988C2 |
| MATRIX TABLET WITH MODIFIED NERAMEXANE RELEASE | 2006 |
|
RU2422135C2 |
| MESALAZINE-BASE PHARMACEUTICAL COMPOSITION FOR ORAL ADMINISTRATION WITH SUSTAINED-RELEASE ACTIVE COMPONENT | 2000 |
|
RU2245148C2 |
| FENOFIBRATE MEDICINAL FORM ELICITING HIGH BIOLOGICAL POTENTIAL AND METHOD OF ITS PREPARING | 1998 |
|
RU2196580C2 |
| PHARMACOLOGICAL COMPOSITION WITH SWELLING COATING | 2004 |
|
RU2375048C2 |
| LENALIDOMIDE TABLET COMPOSITION FOR ORAL ADMINISTRATION | 2017 |
|
RU2725074C1 |
| PHARMACEUTICAL FENOFIBRATE-CONTAINING COMPOSITION ELICITING HIGH BIOLOGICAL POTENTIAL AND METHOD FOR ITS PREPARING | 1998 |
|
RU2238089C2 |
| STABLE PHARMACEUTICAL COMPOSITION CONTAINING WATER-SOLUBLE VINFLUNINE SALT | 2008 |
|
RU2462248C2 |
